跳至主要内容
临床试验/NCT05171413
NCT05171413招募中不适用

Predictive Models of Treatment Responses and Survival Outcomes in Patients With Soft Tissue Sarcoma

West China Hospital1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
800
试验地点
1
主要终点
Progression-free survival outcomes

研究概览

简要总结

The aim of this study was to developed and validated models to predict therapeutic responses and patients' survivals in patients with soft tissue sarcoma and compared these models with currently available models.

详细描述

We performed a retrospective-prospective cohort study with the aim of developing and validating comprehensive models to predict treatment responses and survival outcomes in patients with biopsy-proven soft tissue sarcoma. Secondly, we aimed to compare the predictive accuracy with currently available noninvasive model.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •Receiving no treatment before diagnosis
  • •With written informed consent

排除标准

  • •Clinical data missing
  • •Without written informed consent

结局指标

主要结局

Progression-free survival outcomes

时间窗: At least 5-year follow up

The endpoint was defined as the occurrence of progression or recurrence, or the last follow-up. Patients were followed from the day of histological diagnosis until the occurrence of progression or recurrence, or last visit. The outcome was evaluated by an experienced oncologist in each center every 3-6 months. At each visit, a medical history, physical examination, and standard laboratory tests were performed.

Treatment response

时间窗: At least 1-year follow up

The primary outcome was the evaluation of treatment response to individualized therapy in patients with soft tissue sarcoma.

Overall survival outcomes

时间窗: At least 5-year follow up

The endpoint was defined as the occurrence of death or the last follow-up. Patients were followed from the day of histological diagnosis until the occurrence of progression or recurrence or last visit. The outcome was evaluated by an experienced oncologist in each center every 3-6 months. At each visit, a medical history, physical examination, and standard laboratory tests were performed.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yuhan Yang

Associate Professor

West China Hospital

研究点 (1)

Loading locations...

相似试验